| pSS | primary Sjögren’s syndrome |
| RA | rheumatoid arthritis |
| SLE | systemic lupus erythematosus |
| HNE | 4-Hydroxy-2-nonenal |
| 1-D SDS-PAGE | one-dimensional sodium dodecyl sulfate polyacrylamide gel electrophoresis |
| nano-LC–MS/MS | nano-liquid chromatography–tandem mass spectrometry |
| HC | healthy control |
| Ig | immunoglobulin |
| ACR | American College of Rheumatology |
| IP | immunoprecipitation |
| A1AG1 | α-1-acid glycoprotein 1 |
| RSD | relative standard deviation |
| SD | standard deviation |
| ROC | receiver operating characteristic |
| AUC | area under the ROC curve |
| CBB | Coomassie brilliant blue |
| RF | rheumatoid factor |
| ANA | antinuclear antibody |
| anti-Ro (SSA) | anti-Sjögren’s-syndrome-related antigen A |
| anti-La (SSB) | anti-Sjögren’s-syndrome-related antigen B |
| CRP | C-Reactive protein |
| ESR | erythrocyte sedimentation rate |
| OR | odds ratio |
| ESSDAI | EULAR Sjögren’s syndrome disease activity index |
| NSAIDs | nonsteroidal anti-inflammatory drugs |
| DMARDs | Disease-modifying anti-rheumatic drugs |
| DMARDs | Disease-modifying anti-rheumatic drugs |